Latest Breaking News On - Oral paclitaxel plus encequidar - Page 1 : comparemela.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline – ATNX 04/24/2021 | 01:15am EDT Send by mail : Message : Required fields NEW YORK, April 24, 2021 (GLOBE NEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) and certain of its officers.   The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”).  This action is brought on behalf of the Class for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), 15 U.S.C. §§ 78j(b) and 78t(a)

New yorkUnited statesSan antonioFrance generalLos angelesAbrahaml pomerantzRoberts willoughbyExchange commissionCompany phaseUnited states district courtSecurities exchangeDrug administrationPomerantz firmAthenex incWestern districtSecurities exchange act